Compare REAL & AORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | REAL | AORT |
|---|---|---|
| Founded | 2011 | 1984 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Other Specialty Stores | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.9B | 1.7B |
| IPO Year | 2019 | 1996 |
| Metric | REAL | AORT |
|---|---|---|
| Price | $9.73 | $37.81 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 8 | 5 |
| Target Price | $17.00 | ★ $48.76 |
| AVG Volume (30 Days) | ★ 2.9M | 396.3K |
| Earning Date | 05-07-2026 | 05-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 43.55 | ★ 165.62 |
| EPS | N/A | ★ 0.21 |
| Revenue | ★ $692,845,000.00 | $298,836,000.00 |
| Revenue This Year | $14.30 | $14.20 |
| Revenue Next Year | $10.19 | $11.17 |
| P/E Ratio | ★ N/A | $174.00 |
| Revenue Growth | 15.38 | ★ 18.01 |
| 52 Week Low | $4.71 | $22.22 |
| 52 Week High | $17.39 | $48.25 |
| Indicator | REAL | AORT |
|---|---|---|
| Relative Strength Index (RSI) | 48.36 | 56.85 |
| Support Level | $9.61 | $34.60 |
| Resistance Level | $11.48 | $38.02 |
| Average True Range (ATR) | 0.51 | 1.38 |
| MACD | 0.24 | 0.32 |
| Stochastic Oscillator | 68.57 | 94.92 |
The RealReal is the largest pure-play luxury resale platform in the US, generating $1.8 billion in 2024 gross merchandise volume and addressing a niche (personal luxury resale) that had previously been serviced by inefficient upscale boutiques and local pawn shops. The company generates revenue via consignment and first-party sales on its online marketplace, and through a small volume of direct sales. With a hands-on approach that actively sources inventory and authenticates every item on its platform, The RealReal is able to justify much higher take rates than peers, working out to roughly 36% of net merchandise value in 2024, which excludes returns, cancellations, and first-party sales.
Artivion Inc offers cardiac and vascular surgeons a suite of aortic-centric solutions. The company's products include Aortic Heart Valve, Mitral Heart Valve, Aortic Allograft, Pulmonary Human Heart Valve, Pulmonary Patch, and Surgical Adhesive among others. The company's has two reportable segments: Medical Devices and Preservation Services. The Medical Devices segment includes revenues from sales of aortic stent grafts, surgical sealants, On-X products, and other product revenues. The Preservation Services segment includes services revenues from the preservation of cardiac and vascular implantable human tissues. Company operates in North America, EMEA. LATAM, APAC. Maximum revenue is from North America.